News Center

Category: Uncategorized

July 28, 2023

PGx testing informs clinical management for cancer patients

Somatic testing of solid tumors has become the standard of care. Specific mutations in genes such as BRAF, EGFR, NTRK...
July 7, 2023

Company Spotlight Series: Greice Krautz-Peterson

Meet Greice, Associate Director of Germline Assay Development at Variantyx! This inspired me to get an MS and PhD in...
July 5, 2023

Variantyx updates secondary findings reporting policy to ACMG v3.2

Just 13 days ago, June 22nd to be exact, the American College of Medical Genetics and Genomics (ACMG) published the...
May 25, 2022

Spotlight on inherited ataxias

In its most basic form, ataxia is a neurological symptom. It’s defined specifically as a lack of muscle control or...
May 25, 2022

Spotlight on Fragile X syndrome

Fragile X syndrome (FXS) is one of the most common heritable forms of intellectual disability, occurring in approximately 1 in...
January 26, 2021

Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market

January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®...
September 9, 2019

Cancer predisposition variants: looking beyond BRCA1/2

Everyone has some risk of developing cancer. In fact, nearly 40% of people will be diagnosed with cancer at some...